Citizens Reiterates Market Outperform on TuHURA Biosciences, Maintains $9 Price Target

Benzinga Newsdesk www.benzinga.com Negative 91.7%

Neg 91.7% Neu 0% Pos 0%

Citizens analyst Silvan Turkcan reiterates TuHURA Biosciences (NASDAQ:HURA) with a Market Outperform and maintains $9 price target.